Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product

Lancet

Volumn 348, Issue 9039, 1996, Pages 1413-1416

  Kelly, Judith P ^a   Kaufman, David W ^a   Jurgelon, Jan M ^a   Sheehan, Jane ^a   Koff, Raymond S ^b   Shapiro, Samuel ^a  

^a BOSTON UNIVERSITY   (United States)

^b METROWEST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; EDUCATION; ENDOSCOPY; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MELENA; ONSET AGE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; SEX RATIO; STOMACH MUCOSA;

EID: 0030599533     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)01254-8     Document Type: Article

References (23)

1. 1 Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-94.
2. 2 Holvoet J, Terriere L, Van Hee W, et al. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991; 32: 730-34.
3. 3 Levy M, Miller D, Kaufman DW, et al. Major upper gastrointestinal bleeding and the use of aspirin and other nonnarcotic analgesics. Arch Intern Med 1988; 148: 281-85.
4. 4 Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462-64.
5. 5 Bartle WR, Gupta AK, Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: a case-control study. Arch Intern Med 1986; 146: 2365-67.
6. 6 Carson JL, Strom BL, Soper KA, et al. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987; 147: 85-88.
7. 7 Laporte JR, Carne X, Vidal X, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 85-89.
8. 8 Henry D, Dobson A, Turner C. Variability in the risk of major gstrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterol 1993; 105: 1078-88.
9. 9 Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-78.
10. 10 Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.
11. 11 Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheum 1993; 36: 84-90.
12. 12 Grossman CM. NSAIDs and gut toxicity. Lancet 1994; 344: 57.
13. 13 Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104: 390-98.
14. 14 Gilman AG, Rall TW, Nies AS, eds. Goodman and Gilman's The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990: 644-53.
15. 15 Physicians' desk reference, 49th ed. Montvale, New Jersey: Medical Economics Data Production Company, 1995.
16. 16 Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; 2: 609-12.
17. 17 Lanza FL, Royer GL Jr, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136-38.
18. 18 Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991; 32: 77-83.
19. 19 Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91: 517-20.
20. 20 Schlesselman JJ. Case-control studies: Design, conduct, analysis. New York: Oxford University Press, 1982.
21. 21 Miettinen OS. Estimability and estimation in case referent studies. Am J Epidemiol 1976; 103: 226-35.
22. 22 Fries JF, Ramey DR, Singh G, et al. A reevaluation of aspirin therapy in rheumatoid arthritis. Arch Intern Med 1993; 153: 2465-71.
23. 23 Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-30.